Navigation Links
Recognized Dermatology Expert Dr. Zoe Draelos Joins Histogen Scientific Advisory Board
Date:11/13/2008

Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced that Zoe Diane Draelos, M.D., clinical and research dermatologist and President of Dermatology Consulting Services, has joined the Company's Scientific Advisory Board.

San Diego (PRWEB) November 13, 2008 -- Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced that Zoe Diane Draelos, M.D., clinical and research dermatologist and President of Dermatology Consulting Services, has joined the Company's Scientific Advisory Board.

Dr. Draelos is a board certified dermatologist in private practice, and a recognized expert in cosmetic and biologically active skin medication research. As President and Primary Investigator for Dermatology Consulting Services, a company she founded in 1988, Dr. Draelos is focused on providing education, developing formulation technology, and conducting clinical studies in association with the pharmaceutical and cosmetics industry.

Histogen recently announced the creation of Histogen Aesthetics LLC, a venture developing products for the growing medical aesthetic industries based on the Company's core technology. Dr. Draelos' addition to the Scientific Advisory Board will be invaluable as Histogen Aesthetics moves forward with product launches and further clinical evaluations in this area.

"To have Dr. Draelos, a renowned dermatologist, and skin biologist with focused expertise in cosmetic dermatology, join Histogen's SAB validates our technology and potential for treatments in the growing specialty of aesthetic medicine," stated Lawrence A. Rheins, Ph.D., President of Histogen Aesthetics LLC. "We are excited to have the opportunity to utilize her insight and clinical expertise as we prepare for product launches in post-resurfacing a
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
2. Two Metabolex Projects Recognized in Windhovers Top 10 Lists for Partnering Opportunities
3. BioTrends Research Group, Inc. Recognized as One of Philadelphias Fastest Growing Privately Held Companies
4. Global Vision Recognized for Helping Pharmaceutical Companies Achieve Complete Artwork and Copy Accuracy in their Packaging Process
5. Lilly Recognized as One of the Worlds Top Biopharmaceutical Employers
6. Monsanto Recognized as Top Biotechnology Employer by Science Magazine
7. Titan Spine Teams Up With Syndicom, Inc. to Utilize Internationally Recognized SpineConnect Collaboration Platform
8. Quintiles Recognized Among Best Companies to Work For in Brazil
9. MedNet Solutions Again Recognized as one of the Fastest Growing US Companies
10. Ohio Recognized as National Leader for Business Development and Job Creation
11. Kiwa Bio-Tech Receives Nationally Recognized Organic Products Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... ActiGraph, a leading provider of objective physical ... community, announced today that Dr. Victor KR Matsudo has ... Scientific Director of the Physical Fitness Research Center of ... at Gama Filho University and the Chairman of the ... of Health of São Paulo State, Brazil. , ...
(Date:6/18/2013)... June 18, 2013 Kitware , ... announces a new Fast-Track award from the U.S. Department ... environment (IDAE) for the nuclear power industry. , Construction ... more than 30 years, but the United States’ nuclear ... gains in power plant utilization through improved refueling, maintenance, ...
(Date:6/17/2013)... As a leader in the skincare industry, the team ... for acne, rosacea, and eczema. As part of Acne and ... Rosacea Society) has dedicated a month to creating awareness about ... on treatment options. Probiotic Action follows in the footsteps of ... via social networks and online resources for the acne and ...
(Date:6/17/2013)... LONDON and BOSTON , June ... market is set to reach $127 billion by 2018, accounting ... to the recently released Orphan Drug Report 2013 ... its clients, needs in regard to this growing segment of ... core product database to include in-depth, fact-based orphan drug analysis ...
Breaking Biology Technology:Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board 2Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions 2Evaluate Launches Enhanced Orphan Drug Intelligence 2Evaluate Launches Enhanced Orphan Drug Intelligence 3
... increase 4.2% vs. prior year -DENVER, May 14 Corgenix ... marketer of diagnostic test kits, today filed its third quarter ... the company,s sales have increased during the quarter ended March ... Some of the results highlighted by the report are as ...
... Program Combines Histology, Biomarkers and Non-Invasive Imaging to Demonstrate ... FRANCISCO, May 14 VIA Pharmaceuticals, Inc. ... on the development of compounds for the treatment of ... completed enrollment in a Phase 2 clinical trial of ...
... Dollar Collaboration" -Toronto Stock Exchange Symbol: MSEDMONTON, May ... a leading developer in the treatment of multiple ... Vice President, Commercial Development, BioMS Medical and Mr. ... Lilly and Company, will take part in a ...
Cached Biology Technology:Corgenix Reports Third Quarter Fiscal 2009 Financial Results 2Corgenix Reports Third Quarter Fiscal 2009 Financial Results 3Corgenix Reports Third Quarter Fiscal 2009 Financial Results 4VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 2VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 3VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 4VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 5BioMS Medical to participate in panel session at Bio International Convention 2009 2
(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...
(Date:6/17/2013)... Women in the U.S. exposed to high levels of ... to have a child with autism as women who lived ... from Harvard School of Public Health (HSPH). It is the ... air pollution across the U.S. , "Our findings raise concerns ... women in our study lived in areas where risk of ...
(Date:6/17/2013)... 2013 An international team led by scientists at ... Institute and Albert Einstein College of Medicine of Yeshiva ... that attacks the tuberculosis (TB) bacterium in two different ... solve one of the major global health crises of ... strains," said Peter G. Schultz, the Scripps Family Chair ...
Breaking Biology News(10 mins):The secret of DNA methylation 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4
... Ill Lincoln Park Zoo has been awarded a ... research division, the Urban Wildlife Institute, which will focus ... and utilize sound science to create best practice conflict ... ecology with epidemiology research to create a holistic approach ...
... who has ever battled a stuck zipper knows it,s a ... -- and then to pull hard. , A Cornell research ... mapping the hiccups, stoppages and forces along the way, they ... expressed within cells. , The research, "High-resolution dynamic mapping of ...
... available in German . , The ... is able to rapidly ,and efficiently detoxify chemical warfare ... Tokyo subway attacks in 1995. A detailed understanding ,of ... ,necessary for efforts aiming to improve their properties. A ...
Cached Biology News:Lincoln Park Zoo awarded $1.5 million grant for new research institute 2Researchers 'unzip' molecules to measure interactions keeping DNA packed in cells 2Structure of enzyme against chemical warfare agents determined 2
Recommended for use as a cell culture substratum at 0.1-0.2 mg/cm 2 or 5-10 μl/cm 2 . Optimal concentration depends on cell type as well as the application or research objectives. Type B...
... FROM LIGHT. Useful in cell activation experiments when calcium ... TLC. Soluble in DMSO or EtOH. For ... stock in DMSO is recommended. Microliter amounts of this ... rapid mixing (e.g. 10 μl into 5 ml of ...
... poorly to Protein A and, until recently, no ... step IgM purification. Standard methods for IgM purification ... not effective for removing all of the major ... Pierce has developed an easy-to-use affinity ...
... 3′-(α-Amino- p- methoxyhydrocinnamamido)-3′-deoxy-N,N-dimethyladenosine, 2HCl ... FROM MOISTURE. Protein synthesis inhibitor. Inhibits ... nascent polypeptide chains. Induces DNA fragmentation ... leukemia cells. Purity: ≥98% by ...
Biology Products: